Indication for Modification of Patient Physical Status Clinical Trial
Official title:
A Prospective, Multicenter, Single-arm, Non-controlled Study to Evaluate The Safety and Utility of VelaTM XL Thulium Laser in Cutting And Hemostasis For Gastrointestinal Epithelial Neoplasia In Chinese Population
Prospective, multicenter, single-arm, non-controlled, 60 subjects enrolled and 14 days follow up for evaluate the safety and utility of VelaTM XL thulium laser.
This study aimed to evaluate the safety and utility of VelaTM XL thulium laser in cutting and
hemostasis for gastrointestinal epithelial neoplasia in Chinese population.
Vela China study will enroll at least 60 patients. Follow up points are 72 ±3 hours post
procedure, 7±2 days post procedure, 14 days(±2 days) post procedure.
;